GleamWall
中文EN

SYRA Syra Health Corp

Services-Employment Agencies · OTC · SEC CIK 1922335 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY19.5%
TTM net income YoY155.4%
TTM EPS YoY150.0%
Revenue 3-yr CAGR16.2%
Net income 3-yr CAGR—

Margins

Gross margin42.6%
Operating margin6.8%
Net margin7.8%
FCF margin—
EBITDA margin6.8%

Returns

ROE26.8%
ROA18.7%
ROIC (approx.)109.8%
Asset turnover2.39x

Leverage & solvency

Liabilities / assets28.4%
Debt / equity0.00x
Current ratio3.47x
Interest coverage58.86x

Cash quality & payout

Operating cash flow / net income0.98x
Accruals ratio0.4%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$2.56M$2.39M$2.27M$1.73M$1.69M$1.95M$1.86M$2.01M
Cost of revenue$1.37M$1.33M$1.30M$1.14M$1.13M$1.19M$1.27M$1.55M
Gross profit$1.19M$1.07M$971,255$591,170$554,541$752,895$589,156$455,371
R&D expense$46,716$47,351$6,921$139$816$29,712$37,173-$5,117
SG&A expense$222,141$236,485$213,047$236,635$252,384$289,070$287,287$298,028
Operating income$300,002$251,571$190,983-$135,661-$232,171-$63,158-$473,334-$501,668
Interest expense$1,353$2,217$2,462$4,278$1,905$3,858$3,229$5,528
Pretax income$299,657———-$225,902———
Income tax-$44,953———————
Net income$344,610$250,242$240,979-$134,570-$225,902-$63,596-$472,265-$504,397
EBITDA$300,717$252,312$192,037-$133,364-$226,775-$57,180-$466,537-$494,390
EPS (basic)0.020.020.02—-0.02-0.01-0.04—
EPS (diluted)0.020.020.02—-0.02-0.01-0.04—
Weighted avg. shares (diluted)15.14M13.55M12.78M—11.94M11.94M11.59M—
Balance sheet
Cash & equivalents$2.38M$2.12M$2.92M$1.61M$1.98M$2.31M$2.49M$2.40M
Receivables$1.52M$1.47M$869,132$918,374$926,255$886,361—$680,827
Current assets$4.16M$3.75M$3.93M$2.74M$3.21M$3.43M$3.65M$3.35M
PP&E, net$4,476$5,192$5,932$6,986$9,176$14,572$20,550$27,347
Total assets$4.23M$3.83M$3.94M$2.77M$3.26M$3.47M$3.72M$3.68M
Current liabilities$1.20M$1.20M$1.58M$674,739$1.05M$1.06M$1.27M$613,549
Total liabilities$1.20M$1.20M$1.58M$674,739$1.05M$1.06M$1.27M$800,761
Shareholders' equity$3.02M$2.63M$2.36M$2.10M$2.21M$2.41M$2.46M$2.88M
Cash flow statement
Operating cash flow$331,840-$718,762$1.36M-$289,192-$244,308-$72,477$158,231-$214,720
Capital expenditure———————$0
Free cash flow———————-$214,720
Investing cash flow———————$0
Financing cash flow-$72,174-$79,809-$54,360-$72,513-$85,071-$112,184-$63,051-$87,334
Depreciation & amortization$715$741$1,054$2,297$5,396$5,978$6,797$7,278
Stock-based compensation$45,246$21,095$23,344$23,360$21,127$21,123$32,944$31,317

Free plan shows the latest 8 periods; Pro shows all 17 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.